Cannabis Is Taking on the $1.2 Trillion Pharmaceut
Post# of 4861
Cannabis is ready to find its spot in the $1.2 trillion pharmaceutical industry…
The legalization of cannabis will probably go down in history as one of the greatest advancements in medical history. I’m talking about a discovery as powerful as penicillin or learning how germs cause diseases.
With cannabis, the world of medicine has a real wonder drug on its hands.
I’ve said it before, but it’s worth saying again. Cannabis is the world’s only universal drug because the human body is specifically wired to accept it.
To put this in more precise terms, cannabis has been identified as a potential treatment for no less than 172 different medical conditions.
There may well be more.
Already, though, we know that the conditions that can be treated with the help of cannabis include severe and notorious diseases like cancer, multiple sclerosis, glaucoma, epilepsy, and chronic pain.
Looking at these sectors of the pharmaceutical industry in terms of market size shows us that medical cannabis has plenty of room to expand.
And as it expands, it’s building a new wave of wealth for investors…
Medical Cannabis Disrupting Big Pharma Will Generate Billions
According to Allied Market Research, the annual market for cancer and oncology drugs alone will reach $ 176.5 billion by 2025.
Michael Robinson
Advisory Board Member, National Institute for Cannabis Investors
https://nicinvestors.com/2020/02/28/cannabis-...cal-market